| NCT Number | NCT06949943 |
| Lead Sponsor | Ohio State University Comprehensive Cancer Center |
| Conditions | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 300 participants |
| Start Date | 2025-03-14 |
| Primary Completion | 2027-07-31 (estimated) |
| Study Completion | 2027-07-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-07 |